Mark Douglas Smith Phreesia, Inc. (PHR) insider trading activity

Mark Douglas Smith is Director of Phreesia, Inc.. Currently has a direct ownership of 30,653 shares of PHR, which is worth approximately $576,582. The most recent transaction as insider was on Jul 18, 2024, when has been sold 7,000 shares (Common Stock) at a price of $25.0 per share, resulting in proceeds of $175,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.7K

0% 3M change

38.31% 12M change

Total Value Held $576,582

Mark Douglas Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 18 2024	SELL Open market or private sale	$175,000 $25.0 p/Share	7,000 Reduced 18.59%	30,653 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$32,970 $4.71 p/Share	7,000 Added 15.68%	37,653 Common Stock
Jun 26 2024	BUY Grant, award, or other acquisition	-	8,490 Added 21.69%	30,653 Common Stock
Jun 28 2023	BUY Grant, award, or other acquisition	-	6,051 Added 21.45%	22,163 Common Stock
Apr 03 2023	SELL Open market or private sale	$218,610 $31.23 p/Share	7,000 Reduced 30.29%	16,112 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$32,970 $4.71 p/Share	7,000 Added 23.25%	23,112 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	7,397 Added 31.46%	16,112 Common Stock
Jul 08 2021	BUY Grant, award, or other acquisition	-	2,605 Added 23.01%	8,715 Common Stock
Jan 04 2021	SELL Open market or private sale	$318,120 $53.02 p/Share	6,000 Reduced 49.55%	6,110 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$28,260 $4.71 p/Share	6,000 Added 33.13%	12,110 Common Stock

Also insider at

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

TDOC

Teladoc Health, Inc. Healthcare

Director

MDS